Clinical Trial Information

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis
  • Protocol Number: 16822
  • Status: Open
  • Age Group: Adult
  • Treatment Type: Treatment
  • Phase: III
  • NCT ID: NCT06025578

Scope Information

Scope:
National
Disease Site(s):
Other